Clinical Trial Update: Idebenone for Primary Progressive Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on idebenone for primary progressive multiple sclerosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-19